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Patients with synchronous primary lung and esophageal
carcinoma usually have a history of significant tobacco
and alcohol exposure, low performance status, impaired
pulmonary function, and a tumor burden that does not
permit potentially curative resections.1-3 Operations are
seldom indicated because of the poor prognosis and
expected high surgical morbidity and mortality.
Pneumonectomies are especially to be avoided.1 In this
report, we present the surgical management of a patient
with synchronous, primary, centrally located squamous
cell carcinoma of the lung and esophageal adenocarcino-
ma with Barrett epithelium.
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Fewer than 2% of patients with primary esophageal tumors
have synchronous primary lung cancers, and most of these
tumors have been of squamous cell type.1 Fewer than 60% of
such patients have been treated surgically because of per-
ceived excessive risks. This hesitancy to recommend com-
bined lung and esophageal operations was based on previ-
ously published reports of poor long-term outcomes.1-3 Our
case suggests that surgery should not be categorically denied
and that carefully selected patients with synchronous prima-
ry lung and esophageal cancers should be offered potentially
curative resections. The preoperative work-up should be
directed at determining, insofar as possible, that neither of the
two lesions is a metastasis from the other and that no occult
head and neck cancer exists.
Our patient had severe respiratory dysfunction in addition
to the rare association of a primary squamous cell tumor of
the lung and esophageal adenocarcinoma with Barrett epithe-
lium. Two-stage procedures for similar circumstances have
been described,2,3 starting either with the lung resection or
the esophagectomy. We selected a simultaneous 1-stage ap-
proach, in part to avoid a temporary esophagostomy and in
part to minimize the risk of metastasis from the esophageal
cancer during the interim between operations. Preoperatively,
we were not sure that sleeve lobectomy would be appropriate,
but in preparation for this possibility we harvested the omen-
tum during laparotomy for the purpose of protecting the anas-
tomoses. The lymphatic duct was doubly ligated to avoid the
risk of chylothorax associated with sleeve lobectomy and rad-
ical lymph node dissection.1 The sleeve lobectomy was done
first to avoid contamination of the endobronchial system
when the digestive tract was opened, and the omentum was
used to protect the two anastomoses. Although one may argue
about the oncologic value of sleeve lobectomy, we preferred
it because of the patient’s poor lung function and the risks of
pneumonectomy.1
In summary, a potentially curative operation was success-
fully done to treat synchronous primary squamous cell lung
cancer and esophageal adenocarcinoma. We suggest that this
approach be used for carefully selected patients who have
such cancers.
R E F E R E N C E S
1. Fekete F, Sauvanet A, Kaisserain G, et al. Associated primary
esophageal and lung carcinoma: a study of 39 patients. Ann
Thorac Surg 1994;58:837-42.
2. Fukuda H, Ogino N, Takao T, Kobayashi S, Kido T. A case report
of synchronous double cancer of the lung and esophagus. Nippon
Kyobu Geka Gakkai Zasshi 1990;38:1053-8.
3. Morimoto M, Ohno T, Yamashita Y, Honda M, Asada S. Two sur-
gical synchronous double carcinoma of the lung and the esopha-
gus and review of 10 documented cases. Nippon Kyobu Geka
Gakkai Zasshi 1991;39:245-50.
4. Mathisen D. Ivor Lewis procedure. In: Pearson FG, Deslauriers J,
Ginsberg RJ, Hiebert CA, McKneally MF, Urschel HC, editors.
Esophageal surgery. New York: Churchill Livingstone; 1995. p.
669-76.
1290 Brief communications The Journal of Thoracic and
Cardiovascular Surgery
June 2000
Clinical summary. A 51-year-old man was referred to us
with a history of significant cigarette smoking (30 pack-
years), heavy alcohol consumption, diabetes mellitus (type
IIb), chronic obstructive pulmonary disease, and dilative car-
diomyopathy. He had had gastroesophageal reflux for 2 years
and dysphagia and substernal pain for 1 month. Chest radiog-
raphy and thoracoabdominal computed tomography showed a
centrally located tumor of the right lung without mediastinal
involvement or enlarged lymph nodes in the upper and lower
mediastinum. A sonogram of the celiac region showed no
abdominal adenopathy. Examination with a rigid broncho-
scope identified a squamous cell lung tumor arising from the
right upper lobe and extending beyond the lobar takeoff into
the distal main bronchus. Biopsy specimens of the proximal
right main bronchus and origin of the intermediate bronchus
revealed no cancer at those sites. Esophagogastroscopy and
endoscopic ultrasonography identified a 1 × 1-cm polypoid
intraluminal adenocarcinoma localized in the distal esopha-
gus 30 cm from the incisors, without gastric involvement or
extramural infiltration. Investigations in search of possible
extrathoracic metastasis, including brain computed tomo-
graphic scan, bone marrow scan, and colonoscopy, showed no
cancer. Assessment of the patient’s overall condition revealed
a stable dilative cardiomyopathy with a left ventricular ejec-
tion fraction of 32%, without coronary artery disease, and
liver and kidney function within normal limits. The predicted
forced expiratory volume in 1 second was 66%, predicted
forced vital capacity was 81%, and the ratio of forced expira-
tory volume in 1 second to vital capacity was 89%. The right
lung contributed 51% and 43% of the total ventilation and
perfusion, respectively.
We undertook 1-stage removal of the pulmonary and
esophageal neoplasms in the following sequence. We began
with a laparotomy to accomplish the standard abdominal
preparation of the stomach and lymph node dissection, includ-
ing preservation of the omentum. An intramucosal pylorotomy
was also done. Next, a right upper sleeve lobectomy and radi-
cal mediastinal lymph node resection were done via a pos-
terolateral thoracotomy. Third, the azygos vein and thoracic
ductus were doubly ligated, the esophagectomy was done, and
digestive contiguity was re-established with an esophagogas-
tric Sweet anastomosis4 above the azygos vein. All bronchial,
digestive, and lymph node samples were tumor-free according
to intraoperative frozen sections. The omentum was trans-
posed between the bronchial and esophagogastric anastomot-
ic regions. The final pathology report showed a well-differen-
tiated squamous cell lung carcinoma with one peribronchial
metastatic lymph node (pT2 N1, stage IIB) and an esophageal
adenocarcinoma (pT1 N0) associated with Barrett columnar-
lined epithelium. The postoperative course was uneventful.
The patient resumed eating 7 days after the operation and was
discharged from the hospital 14 days after the operation. No
postoperative chemotherapy or radiation therapy was given.
He is alive and without evidence of disease or postoperative
symptoms 10 months after the operation.
